Cargando…

Isolated myeloid sarcoma of the temporal bone: As the first clinical manifestation of acute myeloid leukemia in a patient of down’s syndrome

INTRODUCTION: Leukemia is the most common malignancy of childhood but myeloid sarcoma is a rare presentation of underlying leukemic disorder. Myeloid sarcoma (MS) is a rare tumor composed of proliferation of myeloid precursors at extramedullary sites. PRESENTATION OF CASE: We report an unusual case...

Descripción completa

Detalles Bibliográficos
Autores principales: Marwah, Nisha, Bhutani, Namita, Budhwar, Archana, Sen, Rajeev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479101/
https://www.ncbi.nlm.nih.gov/pubmed/31015077
http://dx.doi.org/10.1016/j.ijscr.2019.03.027
_version_ 1783413277018030080
author Marwah, Nisha
Bhutani, Namita
Budhwar, Archana
Sen, Rajeev
author_facet Marwah, Nisha
Bhutani, Namita
Budhwar, Archana
Sen, Rajeev
author_sort Marwah, Nisha
collection PubMed
description INTRODUCTION: Leukemia is the most common malignancy of childhood but myeloid sarcoma is a rare presentation of underlying leukemic disorder. Myeloid sarcoma (MS) is a rare tumor composed of proliferation of myeloid precursors at extramedullary sites. PRESENTATION OF CASE: We report an unusual case of myeloid sarcoma involving the temporal bone in a young male child who presented with a large mass involving the left temporal region. This lesion was the initial presentation which led to further diagnosis of acute myeloid leukemia in our case. This case report brings awareness to the diverse extramedullary manifestations of isolated myeloid sarcoma, as well as the importance and difficulties that are associated with establishing a rapid diagnosis and initiating treatment. DISCUSSION: They can arise de novo or in association with hematological malignancies, most commonly acute myeloid leukemia (AML-M2). Clinically, it can masquerade as an abscess, cutaneous ulcer, or as a mass lesion. Morphologically, MS can mimic a variety of small round cell tumors including lymphomas, neuroblatoma and rhabdomyosarcoma. The occurrence of this tumor usually heralds AML or the onset of the blastic phase of chronic myeloid leukemia. Early recognition of this rare entity is important, because early aggressive chemotherapy and focal irradiation can cause regression of the tumor and thus improve patient longevity. CONCLUSION: The possibility of MS should be considered when dealing with unusual lymphoma like neoplasms that cannot be categorized as any of the Non-Hodgkin lymphoma subtypes and small blue round cell tumors.
format Online
Article
Text
id pubmed-6479101
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-64791012019-05-02 Isolated myeloid sarcoma of the temporal bone: As the first clinical manifestation of acute myeloid leukemia in a patient of down’s syndrome Marwah, Nisha Bhutani, Namita Budhwar, Archana Sen, Rajeev Int J Surg Case Rep Article INTRODUCTION: Leukemia is the most common malignancy of childhood but myeloid sarcoma is a rare presentation of underlying leukemic disorder. Myeloid sarcoma (MS) is a rare tumor composed of proliferation of myeloid precursors at extramedullary sites. PRESENTATION OF CASE: We report an unusual case of myeloid sarcoma involving the temporal bone in a young male child who presented with a large mass involving the left temporal region. This lesion was the initial presentation which led to further diagnosis of acute myeloid leukemia in our case. This case report brings awareness to the diverse extramedullary manifestations of isolated myeloid sarcoma, as well as the importance and difficulties that are associated with establishing a rapid diagnosis and initiating treatment. DISCUSSION: They can arise de novo or in association with hematological malignancies, most commonly acute myeloid leukemia (AML-M2). Clinically, it can masquerade as an abscess, cutaneous ulcer, or as a mass lesion. Morphologically, MS can mimic a variety of small round cell tumors including lymphomas, neuroblatoma and rhabdomyosarcoma. The occurrence of this tumor usually heralds AML or the onset of the blastic phase of chronic myeloid leukemia. Early recognition of this rare entity is important, because early aggressive chemotherapy and focal irradiation can cause regression of the tumor and thus improve patient longevity. CONCLUSION: The possibility of MS should be considered when dealing with unusual lymphoma like neoplasms that cannot be categorized as any of the Non-Hodgkin lymphoma subtypes and small blue round cell tumors. Elsevier 2019-03-28 /pmc/articles/PMC6479101/ /pubmed/31015077 http://dx.doi.org/10.1016/j.ijscr.2019.03.027 Text en © 2019 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Marwah, Nisha
Bhutani, Namita
Budhwar, Archana
Sen, Rajeev
Isolated myeloid sarcoma of the temporal bone: As the first clinical manifestation of acute myeloid leukemia in a patient of down’s syndrome
title Isolated myeloid sarcoma of the temporal bone: As the first clinical manifestation of acute myeloid leukemia in a patient of down’s syndrome
title_full Isolated myeloid sarcoma of the temporal bone: As the first clinical manifestation of acute myeloid leukemia in a patient of down’s syndrome
title_fullStr Isolated myeloid sarcoma of the temporal bone: As the first clinical manifestation of acute myeloid leukemia in a patient of down’s syndrome
title_full_unstemmed Isolated myeloid sarcoma of the temporal bone: As the first clinical manifestation of acute myeloid leukemia in a patient of down’s syndrome
title_short Isolated myeloid sarcoma of the temporal bone: As the first clinical manifestation of acute myeloid leukemia in a patient of down’s syndrome
title_sort isolated myeloid sarcoma of the temporal bone: as the first clinical manifestation of acute myeloid leukemia in a patient of down’s syndrome
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479101/
https://www.ncbi.nlm.nih.gov/pubmed/31015077
http://dx.doi.org/10.1016/j.ijscr.2019.03.027
work_keys_str_mv AT marwahnisha isolatedmyeloidsarcomaofthetemporalboneasthefirstclinicalmanifestationofacutemyeloidleukemiainapatientofdownssyndrome
AT bhutaninamita isolatedmyeloidsarcomaofthetemporalboneasthefirstclinicalmanifestationofacutemyeloidleukemiainapatientofdownssyndrome
AT budhwararchana isolatedmyeloidsarcomaofthetemporalboneasthefirstclinicalmanifestationofacutemyeloidleukemiainapatientofdownssyndrome
AT senrajeev isolatedmyeloidsarcomaofthetemporalboneasthefirstclinicalmanifestationofacutemyeloidleukemiainapatientofdownssyndrome